Company Filing History:
2 out of 2 
1 out of 2 
1 out of 12 Years Active: 2018-2024
Title: Huayong Zhou: Innovator in Pharmaceutical Chemistry
Introduction
Huayong Zhou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for cancer treatment. With a total of 4 patents, Zhou's work has the potential to impact therapeutic strategies for various tumors and related diseases.
Latest Patents
One of Huayong Zhou's latest patents is focused on pyridinylaminopyrimidine derivatives. This invention relates to compounds that can selectively inhibit the activity of mutant-type epidermal growth factor receptor (EGFR). The preparation process and use of these derivatives are detailed in the patent, highlighting their effectiveness in inhibiting cancer cell proliferation. These compounds can serve as therapeutic agents for treating tumors and relevant diseases, showcasing Zhou's commitment to advancing medical science.
Career Highlights
Throughout his career, Huayong Zhou has worked with notable companies such as Shanghai Allist Pharmaceuticals Co., Ltd. and Shanghai Allist Pharmaceutical and Medical Tech Co. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Zhou has collaborated with talented individuals such as Huibing Luo and Shuhui Wang. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.
Conclusion
Huayong Zhou's contributions to pharmaceutical chemistry, particularly through his innovative patents, demonstrate his dedication to improving cancer treatment options. His work continues to inspire advancements in the field and holds promise for future therapeutic developments.